HIGHLIGHTS
- who: Danielle Crawley from the Division of Cancer Studies, Cancer Epidemiology Group, Research Oncology, RT, UK have published the paper: Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer, in the Journal: (JOURNAL) of September/09,/2015
- what: The aim of this study is to investigate the biological mechanism of metformin on PCa using pharmacodynamic markers . The investigator also has the right to withdraw patients from the study drug in the event of inter-current illness, AEs, SAE's, SUSAR's, protocol violations, administrative reasons . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.